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1. Introduction 
Our genome contains a higher amount of endogenous retroelements (〜42 %) than mouse (
〜37 %) or fruit fly (〜3.6 %) (1-3). Long interspersed element-1 (L1) is the most abundant of 
transposable elements, comprising 〜17% of the genome (1-4). L1 is an autonomous 
endogenous retroelement that has evolved in a single, unbroken lineage for the past 40 
million years in primates (5). A single human cell has more than 5x105 copies of L1 (2,4), and 
most of them are functionally defective (6). However, 80 to 100 copies of L1 are competent 
for retrotransposition (L1-RTP) (7), and approximately 10 % of these are highly active for 
“copy and paste” (7). L1 is actively expressed in embryonal stem cells (8) and L1-RTP is 
induced in oocytes or early embryonic development (9-11). L1-RTP occurring in germ lines 
would function an intrinsic factor responsible for allelic variants among individuals (12,13). 
However, aberrant L1-RTP alternates critical gene structures, leading to the development of 
inborn errors (14). At the moment, at least 17 genetic diseases have been reported as 
sporadic cases of inheritable disorders caused by aberrant insertion of L1 (14). On the other 
hand, recent observations suggest that L1-RTP occurs in somatic cells. Strikingly, it was 
shown that copy numbers of L1 is increased in human brain tissues (15,16). Aberrant L1 
insertions have been detected in c-myc gene and the APC gene in breast carcinoma and colon 
carcinoma, respectively (17,18). Moreover recent analysis demonstrated that L1 is frequently 
mobilized in human lung cancers and pancreatic carcinomas (19,20). These observations 
indicate that it is important to understand the mode of L1-RTP, but little is known about the 
cellular factors for the induction of L1-RTP in somatic cells. We herein summarize our 
current understanding of L1-RTP induction, with an emphasis on mitogen-activated protein 
kinases (MAPKs), which are activated by environmental compounds, and we discuss their 
roles in genome shuffling.  
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2. Biology of L1-RTP  
L1, a non-long terminal repeat (non-LTR)-type endogenous retroelement, encodes two 
proteins: open reading frames 1 and 2 (ORF1 and 2) (3). ORF1 is a cytoplasmic 40 kDa 
protein that is present within ribonucleoprotein complexes (21-23). ORF1 associates in cis 
with L1-mRNA (24) and functions as a chaperone of L1-mRNA (25). ORF2 is a protein of 
about 150 kDa with dual activities as reverse transcriptase (RT) (26) and an endonuclease 
(27). ORF2 recognizes the 5′-TTAAAA hexanucleotide in the genome and induces a nick 
between 3′-AA and TTTT in the complementary strand (28,29). It has been proposed that the 
first-strand DNA is synthesized by target site-primed reverse transcription (3,29). ORF1 and 
2 complete the entire process of L1-RTP and are competent for the induction of 
retrotransposition of Alu, a non-autonomous retroelements (30, 31). 
3. Reported triggers of L1-RTP  
As to the environmental factors that induce L1-RTP in somatic cells, Farkash et al. reported 
that gamma irradiation at 4.5 Gy induced L1-RTP (32). Independently, Deiniger’s group 
reported that heavy metals of such as mercury, cadmium and nickel also induced L1-RTP 
(33,34). They also reported that nickel-induced L1-RTP is induced by a post-transcriptional 
mechanism (34). As to an environmental carcinogen, Stribinskis and Ramos found that 
benzo[a]pyrene (B[a]P) induced L1-RTP (35). An extensive analysis revealed that aryl 
hydrocarbon receptor (AhR), which serves as a receptor for such environmental pollutants 
as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (36), was required for the B[a]P-induced L1-
RTP (35). Because TCDD, a non-genotoxic hydrocarbon carcinogen, did not induce L1-RTP, 
it was proposed that as one of the its mechanisms an AhR-dependent cellular response 
converts B[a]P into an active genotoxic compound, which in turn induces L1-RTP (35). 
Although the exact modes of L1-RTP are unclear, these studies inspired us to investigate the 
possibility that various environmental compounds can induce L1-RTP.   
4. Induction of L1-RTP by an environmental compound and identification of 
p38 as a pivotal cellular factor  
First, we found that 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoproduct, 
induced L1-RTP (37). FICZ is highly active, and even picomolar comncentratiom of the 
compound induced L1-RTP. In mammalian cells, six groups of MAPKs, namely extracellular 
signal-regulated protein kinase (ERK)1/2, ERK5, JNK, p38, ERK3/4 and ERK7/8, are 
identified, and are activated by intracellular and extracellular stimuli (38). Among these, 
cellular signal cascades of ERK1/2, p38 and JNK have been well characterized, because of 
the availability of inhibitors, including PD98,059, SB202190 and SP600125, respectively. 
Using these MAPK inhibitors, we found that FICZ-induced L1-RTP was dependent on p38 
(37). Interestingly, the compound induced phosphorylation of cyclic-AMP responsive 
element binding protein (CREB), and the down-regulation of endogenous CREB by short 
interference RNA (siRNA) attenuated the induction of L1-RTP by FICZ. Moreover, a 
transfection-back experiment of cDNA that encoded a siRNA-resistant CREB restored the 
induction of L1-RTP. These data indicate that the induction of L1-RTP by FICZ depended on 
p38-CREB-dependent signaling. Intriguingly, L1-RTP by FICZ was not dependent on AhR, 
although FICZ is a candidate physiological ligand of AhR (39). In contrast, L1-RTP by FICZ 
was dependent on AhR nuclear translocator 1 (ARNT1), a binding partner of AhR (40).  
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AhR and ARNT1 are members of the basic helix-loop-helix/per-arnt-sim (bHLH/PAS) 
family, which are transcription factors involved in a variety of biological functions (41). 
Recently, it was shown that the bHLH/PAS family is functionally linked with 
environmental adaptation of living organisms (42). When AhR binds environmental 
compounds, it forms a heterodimer with ARNT1, which is recruited from the cytoplasm to 
chromatin and recognizes a xenobiotic responsive element (XRE) (36). It has been shown 
that the chromatin recruitment of ligand-bound AhR depends on the nuclear localization 
signal of ARNT1 (43), but there are no reports showing that ARNT1 functions as a receptor 
for environmental compounds. A cellular factor that cooperates with ARNT1 in FICZ-
induced L1-RTP has yet to be identified.    
5. MAPKs required for L1-RTP by FICZ 
To explore the involvement of MAPKs in L1-RTP, we extended our experiments to explore 
whether environmental carcinogens induce L1-RTP. In two-stage chemical carcinogenesis, it 
has been shown that skin tumors develop by treatment with 7,12-dimethylbenz[a]anthracene 
(DMBA) plus 12-O-tetradecanoylphorbol-13-acetate (TPA) (44). DMBA functions as an 
initiator and activates H-ras gene, whereas TPA functions as a tumor promoter thorough non-
genotoxic effects (45). However, how TPA induces tumor progression remains to be clarified. 
We first analyzed whether L1-RTP is involved under skin carcinogenesis. When transgenic 
mice harboring human L1 as a transgene (hL1-EGFP mouse) were subjected to DMBA/TPA-
induced skin carcinogenesis, L1-RTP was frequently observed in the DMBA/TPA-induced 
skin tumors (46). Interestingly, in vitro experiments revealed that both DMBA and TPA were 
active for the induction of L1-RTP. On the other hand, in vivo experiments, in which hL1-EGFP 
mice were transiently treated with DMBA or TPA suggested that L1-RTP in the skin tumors 
was attributable to the effects of the repeated treatment with TPA. Notably, we observed that 
the mode of L1-RTP by DMBA and TPA was different. DMBA-induced L1-RTP was 
dependent on both AhR and ARNT1, whereas TPA-induced L1-RTP required neither protein. 
Instead, it depended on ERK1/2 and epidermal growth factor receptor (EGFR). Since Balmain 
et al (44) originally reported on DMBA/TPA-induced two-stage carcinogenesis, a major issue 
of cancer research is to clarify the mechanism of the TPA-induced tumor promotion. Using 
genetically-engineered mice, it has been proven that TPA-induced tumor promotion depends 
on ERK1/2 and EGFR (47,48). Interestingly, TPA-induced L1-RTP was shown to be dependent 
on these molecules, suggesting that the genome shuffling by L1-RTP is linked with the mode 
of TPA-dependent tumor promotion.  
6. MAPKs are involved in the induction of L1-RTP by carcinogens 
Given that environmental compounds seemed to induce L1-RTP by involving different 
cellular proteins, we investigated other carcinogens such as B[a]P and 3-methylcholanthrene 
(3-MC). Consistent with a previous report (35), B[a]P induced L1-RTP in an AhR-dependent 
manner (46). Additionally, 3-MC also induced L1-RTP in an AhR-dependent manner (46). 
However, we found that the L1-RTP was induced even when siRNA against ARNT1 was 
transfected into the cell (Fig. 1b, lanes 9 and 18). The siRNA clearly suppressed the mRNA 
expression of CYP1A1 (Fig. 1c, lanes 11 and 12), indicating that the siRNA effectively 
abrogated the function of endogenous ARNT1 protein. These data support the idea that 
ARNT1 is dispensable for the induction of L1-RTP by these compounds. Because it has been  
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Fig. 1. B[a]P and 3-MC induced L1-RTP depending on AhR and ER, but not on ARNT1. An 
L1-RTP assay was performed according to the procedures described (37,46). Briefly, HuH-7 
cells from a human hepatoma cell line were transfected with pEF06R on day 0, then treated 
with 0.5 g/mL puromycin for two days (days 1-3). The cells were then trypsinized and 
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replated for treatment with the compounds. Two days after the addition of 3 M B[a]P or 1 
M 3-MC, the cells were harvested and their DNA extracted. No cytotoxicity was caused by 
3 M B[a]P or 1 M 3-MC (data not shown). For the PCR-based assay, a spliced form of 
EGFP cDNA (140 bp in length) was amplified by PCR with primers specific for the 
separated exons of EGFP cDNA. The amplified DNA was then loaded onto an agarose gel 
and detected after staining with SYBR Green. As an internal control, the same samples were 
used as templates for the amplification of -actin. a. Effects of ARNT1 siRNA on the down-
regulation of endogenous ARNT1. Western blot analysis was performed on day 2 after the 
transfection of ARNT1 siRNA. U, untreated; C, control siRNA; ARNT1, ARNT1 siRNA. b. L1-
RTP caused by B[a]P and 3-MC was independent of ARNT1. The PCR-based assay of the 
effects of ARNT1 siRNA is shown. HuH-7 cells were transfected with pEF06R on day 0 and 
then selected from days 1-3. On day 3, the cells were trypsinized, replated, and further 
transfected with control (Cont.) or ARNT1 siRNA. On day 4, the cells were again divided into 
three groups and treated with DMSO, 3-MC (left panel), or B[a]P (right panel). After two days, 
DNA was extracted and subjected to a PCR-based assay. The arrowhead indicates the PCR-
amplified band corresponding to the induction of L1-RTP. c. ARNT1 siRNA effectively 
blocked the mRNA expression of CYP1A1, which was induced by the compounds. HuH-7 
cells were first transfected with control or ARNT1 siRNAs. On day 2 after transfection, the cells 
were trypsinized, replated, and treated with B[a]P or 3-MC. RT-PCR analysis was performed 
on day 2 after the addition of the compounds. d. ER is required for the induction of L1-RTP 
by B[a]P or 3-MC. In this experiment, MCF-7 cells from a human breast carcinoma cell line 
were used. Using a similar experimental protocol, the effect of ER siRNA on the induction of 
L1-RTP was examined. As an internal control, -actin was amplified.  
Cellular factors 
Inducers 




















SB202190 ○ ○ ○ - - 
SP600125 - ○ ○ - - 
PD98,059 N.T. N.T. N.T. - ○ 
○, dependent; -, independent; N.T., not tested. 
The induction of L1-RTP was examined by a PCR-based assay (see legend for Fig. 1). 
Table 1. Summary of cellular factors required for L1-RTP by environmental compounds 
shown that AhR forms a complex with estrogen receptor  (ER we further tested the 
involvement of ER in the induction of L1-RTP. Interestingly, the transfection of ERsiRNA 
attenuated L1-RTP induced by these compounds (Fig. 1d, lanes 5 and 6). In addition, we 
found that CREB was definitely phorphorylated (Fig. 2a, lane 4), and checked the effects of 
MAPK inhibitors on the induction of L1-RTP by 3-MC. As shown in Fig. 2b, SB202190 
attenuated the induction of L1-RTP (lane 8), whereas SP600125 did not (lane 10). To further 
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identify a candidate substrate of p38, we examined the effects of CREB siRNA. The 
transfection of CREB siRNA abrogated the induction of L1-RTP by 3-MC (Fig. 2c). These 
data suggest that L1-RTP by 3-MC is induced by the cooperative function of AhR and ER 
depending on a signal cascade involving the p38-CREB pathway. Our data also indicate that 
the induction of L1-RTP by B[a]P is dependent on p38 and JNK (Fig. 2d, lanes 8 and 10). 
Although further study is required, our current understanding is that various environmental 
compounds induce L1-RTP by combinations of the bHLH/PAS family and MAPKs (Table 
1). L1-RTP was differentially induced by FICZ, DMBA, B[a]P, 3-MC and TPA. Most of the 
compounds examined, with the exception of DMBA, depended on MAPKs. Moreover, the 
L1-RTP by carcinogens depended on AhR, whereas FICZ did not. It is important to collect 
more information about chemical compounds active in the induction of L1-RTP and to 
elucidate the involvement of MAPKs.  
It has been proposed that L1-RTP is controlled at the transcriptional and post-transcriptional 
levels. In vitro experiments revealed that that the expression of L1 is tightly regulated by 
methytlation of CpG in the region of 5’-LTR. In normal somatic cells, the 5’-LTR of L1 is 
methylated at CpG (50,51), but it is hypomethylated in transformed cells (52). It has been 
consistently reported that treatment with B[a]P induced the hypomethylation of CpG in 
HeLa cells (53). Moreover, it was reported that L1-5’UTR has a ubiquitously active antisense 
promoter that encodes small interfering RNAs, which effectively suppressed the 
retrotransposition of L1 (54). These observations indicate that epigenetic alternation of the 
5’-UTR was proposed as the activation mode of L1-UTR by the compound. However, the 
following in vitro experiments suggested the presence of another regulatory system of L1-
RTP. A reporter construct was transfected into cultured cells, and treatment with the 
compounds increased the frequency of L1-RTP. Because the reporter construct (e.g., pEF06R, 
which carries EGFP cDNA as a reporter gene) contained a potent CMV promoter (32,34), L1-
mRNA was strongly expressed when it was transfected into cultured cells. Even under such 
conditions, remarkable effects on the induction of L1-RTP were detectable by additing 
inducers such as FICZ, B[a]P, and 3-MC (37,46). Data indicate the presence of an additional 
regulatory system in which cellular proteins regulate the induction of L1-RTP. One possible 
mode of regulation is the chromatin recruitment of ORF1. 
7. The chromatin recruitment of ORF1 is MAPK-dependent  
Because it has been postulated that ORF1 is present in the cytoplasm (21-23) and carcinogen-
induced L1-RTP was dependent on AhR, it is plausible that ORF1 is functionally associated 
with the bHLH/PAS family. To prove this, we evaluated the association of ORF1 and AhR 
by an immunoprecipitation followed by Western blot analysis with a polyclonal antibody to 
human ORF1. Intriguingly, ORF1 and AhR were associated even under normal conditions 
(Okudaira N, submitted). More importantly, we detected that recruitment of ORF1 into the 
chromatin-rich fraction was coupled with L1-RTP. As reported, chromatin recruitment of 
ORF1 was induced by FICZ in a MAPK-dependent manner. It is interesting that the 
chromatin recruitment of ORF1 was induced by FICZ, although FICZ-induced L1-RTP was 
not dependent on AhR (37). Interestingly, ARNT1 was associated with ORF1 when FICZ 
was added to the culture medium (37). Although the precise role of the MAPK is unclear, 
these data suggest that the chromatin recruitment of ORF1 is the important regulatory step 
in L1-RTP, where at least p38 is involved as a crucial cellular factor.  
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Fig. 2. MAPK is required for the induction of L1-RTP by B[a]P or 3-MC. a. Phosphorylation 
of MAPK substrates induced by 3-MC. HuH-7 cells were analyzed on day 2 after the 
addition of the compound. U, untreated; D, dimethylsulfoxide (DMSO); F, FICZ; M, 3-MC; 
H, H2O2. b. Effects of MAPK inhibitors on L1-RTP induced by 3-MC. SB and SP are 
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SB202190 and SP600125, respectively. U, untreated; D, DMSO; F, FICZ; M, 3-MC; H, H2O2. 
Of note, L1-RTP caused by 3-MC was attenuated by SB (lane 8), but not by SP (lane 10). The 
arrowhead indicates the induction of L1-RTP. c. CREB is required for L1-RTP induced by 3-
MC. Left panel: Western blot analysis detected efficient down-regulation of the endogenous 
protein by CREB siRNA. U, untreated; N, non-transfected; C, control siRNA; CREB, CREB 
siRNA. Right panel: PCR-based assay after the transfection of CREB siRNA. CREB siRNA 
attenuated L1-RTP induced by 3-MC (lane 9). d. Effects of MAPK inhibitors on L1-RTP 
induced by B[a]P. Reagents similar to those described in Fig. 2b were used. L1-RTP by B[a]P 
was attenuated by both SB (lane 8) and SP (lane 10). 
8. Roles of MAPK on L1-RTP  
It has been supposed that the increase of transposable elements coupled with evolution (7). 
Even in Candida albicans, an L1-like structure is present as a functional gene (55). On the other 
hand, the bHLH/PAS family, which has a variety of biological functions including the 
metabolism of xenobiotics, maintenance of the circadian rhythm, cellular responses to hypoxia, 
and neuronal differentiation (41,42), is also well conserved from lower species to mammals 
(56). Interestingly, AhR homologs are also present in the genomes of Drosophila melanogaster 
and Caenorhabditis elegans (56). Although no direct evidence on the functional relationship 
between these two biological phenomena has been claimed, our observation is the first to 
demonstrate the functional link of these biological events. Moreover, data suggest that MAPKs 
are involved in the bHLH/PAS-dependent L1-RTP. MAPKs are involved in cellular response 
to intracellular and extracellular stress (38,57), and it is plausible that MAPKs mediate various 
stresses in the induction of L1-RTP, resulting in genome shuffling. Random mutagenesis by 
L1-RTP may give emerging novel organisms to survive in altered environments.  
It is important to clarify the roles of MAPKs in the induction of L1-RTP. At present, at least 
two functions of MAPKs can be postulated. As explained, environmental compounds 
activate MAPKs, by which the chromatin recruitment of ORF1 is induced as a necessary step 
in L1-RTP. ORF1 functions in cis with L1- mRNA and functions as a chaperon of L1-mRNA 
(24,25). Using MAPK inhibitors, we observed that L1-RTP was abrogated concomitantly 
with the reduced chromatin recruitment of ORF1. These observations suggest that MAPK 
activation drives the mobilization of ORF1 to chromatin, by which retroelements are 
translocated to chromtin.  
Another possible role for MAPKs is related to the activity of the APOBEC family. It has been 
proposed that APOBEC family functions as innate restriction factors that suppress the 
activity of endogenous retroelements (58). Originally, it was postulated that the APOBEC 
family inhibits HIV-1 infection by editing C to T via deaminase activity (58). Vif, a gene 
product of HIV-1, degrades APOBEC proteins, causing infected cells to become permissive 
for HIV-1 infection (59). We previously showed that all members of the APOBEC family 
exhibit inhibitory activity toward L1-RTP (60). However, it was recently postulated that the 
APOBEC has dual activity (61) and inhibits the activity of RT (62). In in vitro experiments in 
which APOBEC3G were added to the reaction of RT in the synthesis of viral DNA, APOBEC 
interfered with elongation of the viral DNA (62). Interestingly, it has been shown that 
C/EBP- bound APOBEC3G and attenuate the inhibitory activity of APOBEC3G (63). 
Moreover, it was demonstrated that the mutation of serine at 228 (S228),the phosphorylation 
of which is correlated with the cytoplasmic localization of the molecule (63), abolished both 
binding and inhibitory activity on APOBEC3G (64). Given that C/EBP-is a substrate of p38 
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(38), a plausible model is that p38 augments the blocking activity of C/EBP- on APOBEC3G 
via phosphorylation.  
9. Further implications 
Ataxia telangiectasis mutated (ATM), a phosphoinositide 3-kinase, has a functional link with 
L1-RTP (16). In an intriguing recent observation, the copy number of L1 increased in the 
brain tissues of patients with ATM (16). L1-RTP is consistently increased in the brain tissue 
of ATM-knock out mouse. Although these observations suggest that ATM functions as a 
negative regulator of L1-RTP, Gasior et al. originally reported that ATM was required for the 
induction of L1-RTP (65). Because of controversial observations regarding the role of ATM 
in L1-RTP, we focused on MAPKs in the current study.  
Recent observations revealed that genome shuffling by L1-RTP in human somatic cells is a 
source of interindividual genomic heterogeneity (12,13). In addition, independent research 
groups reported that L1-RTP is frequently induced in tumors (19,20), suggesting the 
involvement of L1-RTP in the development of carcinogenesis. Importantly, L1 proteins are 
active on the retrotransposition of Alu (30,31), a non-autonomous retoroelement. On the other 
hand, it has been shown that Alu induces genomic instability via non-allelic homologous 
recombination (66). Thus, it is important to understand the activation mechanisms of L1. Our 
current observations support the idea that the chromatin recruitment of ORF1, which is 
controlled by cooperative regulation by members of the bHLH/PAS family and MAPKs, is a 
critical step in the regulation of L1-RTP. If this is the case, L1-RTP induction in the genome is 
selectively determined by cellular factors. Because AhR is a transcription factor that 
recognizes specific nucleotide element (36), carcinogens possibly induce L1-RTP in the 
genomes in the vicinity of the cis-element.  
As observed in the analysis of L1-RTP by B[a]P and 3-MC, L1-RTP was not induced via the 
classical pathway controlled by both AhR and ARNT1. Our data suggest that L1-RTP is not 
necessarily induced by genotoxic activities of these compounds, further implying that L1-RTP 
is a novel type of genomic instability by which cellular cascades activated by environmental 
compounds lead to genome shuffling and generate stable phenotypes of the affected cells. The 
suppression of L1-RTP in somatic cells by targeting MAPK activity may be a novel strategy to 
protect the development of intractable diseases that include carcinogenesis.    
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